Cochlear, CSL and Pro Medicus have been hard hit by disparate concerns, many of which investors suspect are structural rather ...

The decision to place cochlear implants in both ears at the same time in young children may better shape brain development ...

A cochlear implant, a small yet complex electronic device, is emerging as a transformative solution for individuals with severe hearing loss, enabling them to perceive sound and significantly improve ...

Detailed price information for Envoy Medical Inc (COCH-Q) from The Globe and Mail including charting and trades.

The implantable medical devices market offers opportunities driven by rising chronic diseases, aging populations, and technological advancements like smart and biocompatible materials. Regions like ...

Envoy Medical Inc, a hearing health company pioneering fully implanted hearing solutions, announced that all 56 patients implanted and enrolled in its pivotal clinical trial evaluating the fully ...

Cochlear’s shares have collapsed after the hearing implants behemoth again downgraded profit guidance by up to $170m on ...

After both crashing more than 38% since the start of the year, these ASX healthcare stocks are receiving mixed views from ...

The FDA has granted accelerated approval to Regeneron’s Otarmeni, the first gene therapy for OTOF-related inherited hearing loss, following strong early trial results in children and adolescents. The ...

Oklahoma boy hears clearly for the first time with cochlear implant ...

Cochlear also said that trading conditions for implants in developed markets have been softer-than-expected, while the fourth ...

WHITE BEAR LAKE, Minn. - Envoy Medical, Inc. (NASDAQ:COCH) announced that the first three patients in its pivotal clinical trial for the Acclaim cochlear implant completed their 12-month endpoint ...